All studies mentioned above showed that SCNN1B may act as a tumor suppressor, but in GEPIA database, the patients with high SCNN1B mRNA expression level suffer a poor survival prognosis (p = 0.091). This evidence concerns the gene SCNN1B and neoplasm.